Arena Pharmaceuticals, Inc. (ARNA)

[bell345]

I hope they don't knock down the price because some of the gain was non-cash items

"Revenues include a significant amount of non-cash items, particularly accelerated upfront fees from our lorcaserin arrangement that were deferred, and revenues for product sales that were previously required to be deferred upon accounting guidance. Additionally, cost of product sales, R&D expenses, and impairment of long-lived assets were impacted by the Eisai transaction.

General tone of CC was very good.


I did get a gain of about 350.00 in AH's trading...GL longs

http://finance.yahoo.com/news/edited-transcript-arna-earnings-conference-020651485.html